PerkinElmer to acquire antibodies and reagents manufacturer BioLegend
PerkinElmer has signed a cash and stock deal worth around $5.25 billion to acquire BioLegend, a California-based antibodies and reagents manufacturer. BioLegend caters to academic ... Read More
PerkinElmer to acquire Oxford Immunotec for $591m to expand tuberculosis testing capabilities
In a significant move within the diagnostics sector, US-based PerkinElmer has announced its agreement to acquire UK-based Oxford Immunotec for $591 million, translating to $22 ... Read More
PerkinElmer to acquire cell engineering company Horizon Discovery
US-based PerkinElmer will acquire UK-based cell engineering company Horizon Discovery Group for nearly $383 million in an all-cash deal. The transaction, which is subject to ... Read More